Vancouver, BC, February 3, 2020--Vesalius Cardiovascular Inc. (VCI), a pre-clinical stage medical device company developing novel percutaneous therapies for the treatment of mitral regurgitation, has announced the successful completion of their first 30-day chronic animal study using their mitral valve repair device.

Vancouver, BC, June 25, 2019--Vesalius Cardiovascular has taken home the 2019 Innovators' Challenge presented by the VGH and UBC Hospital Foundation, winning the top prize of $300,000.

Vancouver, BC, December 11, 2017--e@UBC announced that Vancouver-based BioMed Startup Vesalius Cardiovascular won the top prize at the annual Cascadia Venture Forum (CVF) Summit, recently hosted at Cambia Grove in Seattle on November 15, 2017.